Insights into recent findings and clinical application of YAP and TAZ in cancer

JM Franklin, Z Wu, KL Guan - Nature Reviews Cancer, 2023 - nature.com
Decades of research have mapped out the basic mechanics of the Hippo pathway. The
paralogues Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding …

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer

R Cunningham, CG Hansen - Clinical Science, 2022 - portlandpress.com
Tumorigenesis is a highly complex process, involving many interrelated and cross-acting
signalling pathways. One such pathway that has garnered much attention in the field of …

Hippo–YAP/TAZ signalling in organ regeneration and regenerative medicine

IM Moya, G Halder - Nature reviews Molecular cell biology, 2019 - nature.com
The Hippo pathway and its downstream effectors, the transcriptional co-activators Yes-
associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) …

Pharmacological blockade of TEAD–YAP reveals its therapeutic limitation in cancer cells

Y Sun, L Hu, Z Tao, GK Jarugumilli, H Erb… - Nature …, 2022 - nature.com
Targeting TEAD autopalmitoylation has been proposed as a therapeutic approach for YAP-
dependent cancers. Here we show that TEAD palmitoylation inhibitor MGH-CP1 and …

YAP/TAZ upstream signals and downstream responses

A Totaro, T Panciera, S Piccolo - Nature cell biology, 2018 - nature.com
Cell behaviour is strongly influenced by physical, mechanical contacts between cells and
their extracellular matrix. We review how the transcriptional regulators YAP and TAZ …

YAP and TAZ: a signalling hub of the tumour microenvironment

F Zanconato, M Cordenonsi, S Piccolo - Nature Reviews Cancer, 2019 - nature.com
YAP and TAZ are transcriptional activators pervasively induced in several human solid
tumours and their functions in cancer cells are the focus of intense investigation. These …

YAP/TAZ at the roots of cancer

F Zanconato, M Cordenonsi, S Piccolo - Cancer cell, 2016 - cell.com
YAP and TAZ are highly related transcriptional regulators pervasively activated in human
malignancies. Recent work indicates that, remarkably, YAP/TAZ are essential for cancer …

Binary pan-cancer classes with distinct vulnerabilities defined by pro-or anti-cancer YAP/TEAD activity

JD Pearson, K Huang, M Pacal, SR McCurdy, S Lu… - Cancer Cell, 2021 - cell.com
Cancer heterogeneity impacts therapeutic response, driving efforts to discover over-arching
rules that supersede variability. Here, we define pan-cancer binary classes based on distinct …

Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer

S Ma, T Tang, G Probst, A Konradi, C Jin, F Li… - Nature …, 2022 - nature.com
Extensive knowledge has been gained on the transcription network controlled by ERα,
however, the mechanism underlying ESR1 (encoding ERα) expression is less understood …

Interplay between YAP/TAZ and Metabolism

JH Koo, KL Guan - Cell metabolism, 2018 - cell.com
Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ)
are two homologous transcriptional coactivators that promote cell proliferation, stem cell …